Cancer-testis antigen BORIS is a novel prognostic marker for patients with esophageal cancer
Cancer Science, 06/08/2012
Clinical Article
Okabayashi K et al. – BORIS may be a useful biomarker for prognostic diagnosis of Esophageal squamous cell cancer (ESCC) patients and a potential target for treatment including by BORIS–specific immunotherapy and molecular target therapy.



